Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment
Alessio Baricich(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Marco Invernizzi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Nicola Smania(University of Verona), Andrea Santamato(University of Foggia), Alessandro de Sire(Magna Graecia University), Stefano Carda(University Hospital of Lausanne), Carlo Cisari(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Alessandro Picelli(University of Verona)
Cited by 49
Related Papers
Pathophysiology of Motor Dysfunction in Parkinson’s Disease as the Rationale for Drug Treatment and Rehabilitation
|Parkinson s Disease|2016|374
Virtual Reality Telerehabilitation for Postural Instability in Parkinson’s Disease: A Multicenter, Single-Blind, Randomized, Controlled Trial
|BioMed Research International|2017|325
Sarcopenic Dysphagia, Malnutrition, and Oral Frailty in Elderly: A Comprehensive Review
|Nutrients|2022|268
Rehabilitation procedures in the management of spasticity.
|PubMed|2010|168